DOI: 10.1177/13524585241235542 ISSN: 1352-4585
Neoehrlichiosis associated with ocrelizumab in a patient with multiple sclerosis: A case report
Raja Majid Afzal, Jeppe Romme Christensen, Rosa Maja Møhring Gynthersen, Anne-Mette Lebech, Morten Blinkenberg, Helene Mens- Neurology (clinical)
- Neurology
Objective:
To describe a case of neoehrlichiosis, an emerging opportunistic tick-borne infection, in a patient with multiple sclerosis (MS) treated with ocrelizumab.
Methods:
This is a case study.
Results:
Our patient developed clinical infection over several months while on ocrelizumab and was ultimately diagnosed with neoehrlichiosis, caused by the bacteria Neoehrlichia mikurensis. Resolution of symptoms began within a few days after the initiation of antibiotic treatment.
Conclusion:
We describe the first probable case of ocrelizumab-associated neoehrlichiosis in a patient with MS. Clinicians should be aware of this potentially debilitating and life-threatening infection in patients receiving CD20-depleting therapy.